The history of Viagra, originally marketed by copyright, presents a complex case study for stakeholders considering the pharmaceutical sector. Although its early success and generation of vast in earnings , the patent end has opened the door for generic medications, greatly diminishing earnings opportunities. This shift raises concerns about the lo